A diagnosis of posttransplantation human herpesvirus-6 (HHV-6) infection was established for eight adult recipients among a liver transplantation patient population of 121. The diagnosis was based on serology and demonstration of HHV-6 specific antigens in liver biopsy specimens with use of monoclonal antibodies and immunoperoxidase staining. A significant graft dysfunction was recorded in association with serodiagnosis. HHV-6 early antigens, as well as HHV-6 variant B antigens, were detected retrospectively in all six available liver biopsy specimens. Histologic examination of biopsy specimens demonstrated acute rejection in 5 of the 8 patients, and 3 patients had portal lymphocyte infiltration. In five cases cytomegalovirus (CMV) infection was associated with HHV-6 infection; in four cases CMV antigens were also detected in the biopsy specimens. Two patients who had pure HHV-6 infection without CMV infection or rejection had significantly impaired graft function, with a positive antigen-detection test. Thus, HHV-6 may infect the liver allograft and cause graft dysfunction and may possibly be associated with rejection and/or CMV infection.
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Human herpesvirus-6 (HHV-6) is one of the newest charac-
In particular, an association with allograft rejection, as well as with CMV infection, has been suggested [18, 19] . terized members of the family of human herpesviruses [1 -3] . Two major subgroups of the virus, variant A and variant B,
Herein we describe posttransplantation HHV-6 infection in eight adult liver transplant recipients. The diagnosis of HHV-6 have been identified [4] . Like other herpesviruses, HHV-6 can establish a latent or persistent infection that remains for the was based on both serology (performed because of clinical suspicion of viral infection) and antigen detection in liver bilifetime of the host and can reactivate during immunosuppression. The virus is closely related to human cytomegalovirus opsy specimens (obtained because of graft dysfunction). The HHV-6 infections are described in relation to acute rejections (CMV), and there are homologues between the two viral gene families [5, 6] . The clinical picture of HHV-6 infection varies and CMV infections. from asymptomatic or a mild skin rash of exanthema subitum in infants to a febrile, severe or fatal disseminated disease in
Patients and Methods immunocompromised patients [3, 7] . In addition to dissemiPatients. During a 3-year period, since routine HHV-6 senated infections, lymphadenopathy, encephalopathy, pneumorology became available, HHV-6 infection was noted in eight nitis, and hepatitis due to HHV-6 have also been described adult liver transplant recipients among the patient population [8 -12] .
of 121 undergoing posttransplantation clinical follow-up at our HHV-6 infections complicating the postransplantation pecenter. The posttransplantation follow-up time for the patients riod have been reported to occur in bone marrow, kidney, and varied from 1 to 9 years (median, 60 months). As basic immuliver transplant recipients [9, 12 -16] . In renal transplantation, nosuppression, the patients received triple-drug therapy with the frequency of active HHV-6 infection has been reported various combinations of steroids, cyclosporine, and azathioto vary between 38% and 82% [13, 14] , and asymptomatic prine. Acute rejections were treated with a high dose of methylseroconversions or increases in antibody titer are thought to be prednisolone, and steroid-resistant rejections were further common. The presence of HHV-6 specific antigens in renal treated with OKT3. Diagnosis of rejections was based upon biopsy material has been demonstrated in association with other histologic findings at biopsy. pathological conditions of kidney allografts, such as acute and Laboratory diagnostics for viral infections were performed chronic rejection or cyclosporine-related nephropathy [17, 18] . only in association with clinical suspicion. Severe CMV infections were treated with ganciclovir. Diagnosis of CMV infection was based on viral culture findings and detection of CMV-and direct detection of HHV-6-specific antigens in the liver CA) were used as second and third antibodies. The reaction was revealed by 3-amino-9-ethyl carbazole solution containing biopsy material. The serum specimens were obtained only because of clinical suspicion of viral infection, and no regular hydrogen peroxide. Mayer's hemalum was used for counterstaining. Biopsy specimens (n Å 58) from the liver transplant follow-up of HHV-6 serology was performed for these patients. The liver allograft biopsies were performed because of graft recipients without serological evidence of HHV-6 infection were used as controls; 7 of these patients experienced acute dysfunction, to diagnose possible rejection or intragraft infections.
rejection, and 11 were positive for CMV antigens but had no evidence of HHV-6 infection or rejection. Histologic examination was performed on formalin-fixed and paraffin-embedded specimens of the same biopsy material.
Liver biopsy histology. Liver allograft biopsy specimens were fixed in 10% buffered formalin and embedded in paraffin HHV-6 antigen detection was performed retrospectively on the available liver biopsy specimens obtained during the infection wax. Four-micron-thick sections were prepared with a panel of five stains -hematoxylin-eosin, methyl green pyronin, Masepisode. Biopsy specimens of adult liver-transplant recipients with graft dysfunction but without serological evidence of son's trichrome, diastase-PAS, and reticulin -to evaluate the histologic changes in the transplants. The histological diagnosis HHV-6 infection were used as negative controls because no liver biopsy specimens from seronegative infants were availof acute hepatic allograft rejection was based on three main findings (which were also recommended recently [22] ): mixed able.
Serology. The HHV-6 antibody assay was performed by but predominantly mononuclear portal inflammation, bile duct inflammation and/or damage, and endotheliitis of portal means of an indirect immunofluorescence test with use of HHV-6-infected HSB-2 cells (a continuous immature T-lymand/or terminal veins. At least two of these three alterations were required for the diagnosis. phoblastoid cell line) as antigens, as described in detail previously [21] . The acetone-fixed HHV-6-infected HSB-2 cells
Ethical considerations. All liver biopsy material investigated in this study was obtained because of clinical indications were incubated on object glass with patient serum samples at twofold dilutions of 1:10 to 1:160 for 30 minutes at 37ЊC and for histopathology. rinsed three times with PBS and once with distilled water. The second incubation was with fluorescein isothiocyanate (FITC) -Results conjugated goat antibody to human immunoglobulin (Kallestad, Austin, TX).
The appearance of HHV-6 infection, histologic findings in the liver biopsy related to HHV-6 serodiagnosis, CMV infecAfter being washed, the slides were examined with a fluorescence microscope. A serum known to contain HHV-6 antitions with antiviral treatments, and antirejection treatments are summarized in table 1. During a 3-year period, in a patient body served as a positive control, and uninfected HSB-2 cells were used as a negative cell control. The titer was considered population of 121 adult liver transplant recipients undergoing clinical posttransplantation follow-up at our center, eight cases the reciprocal value of the last dilution sharing a virus-specific fluorescence. Altogether, 179 serum specimens obtained from of HHV-6 infection were diagnosed by serology; infection appeared between 10 days and 5 years after liver transplantation. the liver transplant recipients were analyzed. The serological diagnosis of HHV-6 infection was based on a fourfold increase
In four of the 8 cases, HHV-6 infection appeared within 2 months postoperatively. The other four HHV-6 infections were in the antibody titer. In addition, an increase in titers to §1:160 was also considered diagnostic. Titers of §160 were considdiagnosed late in the recipients' follow-up course. A significant elevation of serum ALT (range, 182 -1,550 IU), ALP ered significant because of their high association with recent infection [21] , on the basis of an earlier serological screening (629 -1,875 IU), g-GT (618 -1,770 mmol/L), and bilirubin (32 -360 mmol/L) values was recorded in association with the survey of the Finnish adult population.
Detection of HHV-6 antigens in liver biopsy specimens. For serological diagnosis. Five patients also had fever. HHV-6 early antigens were detected in all six available liver HHV-6 antigen detection, the liver transplant core needle-biopsy material was snap-frozen, and sections (3-4 m) were cut, acetonebiopsy specimens obtained during the episode of graft dysfunction, which was closely concomitant with the serological diagfixed, and stored at 020ЊC until used. The presence of viral antigens was demonstrated by an indirect three-layer immunoperoxidase nosis of HHV-6 infection. The HHV-6 antigens were located in scattered mononuclear leukocytes infiltrating the graft, staining and a monoclonal antibody to an early HHV-6-specific antigen (MAB8533; Chemicon International, Temecula, CA) and mainly in the portal fields (figure 1). On the basis of their morphology, most antigen-positive cells were lymphocytes. In another monoclonal antibody to HHV-6 variant B virion protein of 101 kD (MAB8535, Chemicon).
all six cases, HHV-6 variant B -positive leukocytes were also detected in the graft. HHV-6 antigens were not seen in the Before staining, the sections were treated with chloroform to eliminate nonspecific reactions due to endogenous peroxiparenchymal cells of the liver. HHV-6 antigens were not detected in 39 liver biopsy specimens used as controls and obdase. A peroxidase-conjugated rabbit antibody to mouse immunoglobulin (Dako, Copenhagen) and a peroxidase-conjugated tained because of graft dysfunction from 19 patients without serological evidence of HHV-6 infection. goat antibody to rabbit immunoglobulin (Tago, Burlingame, / 9c48$$mr49 02-11-98 09:46:29 cida UC: CID Biopsy histologic findings, obtained because of impaired cases) during the period of HHV-6-associated graft dysfunction. graft function in association with HHV-6 infection, demonstrated signs of acute rejection in five patients. The other three
In five of the eight cases, CMV antigenemia was associated with HHV-6 infection. In four patients CMV antigens were biopsy specimens had mild to moderate portal inflammatory infiltration with lymphocytic predominance, but the criteria of also demonstrated in the liver biopsy specimens, indicating graft affection. Five patients were treated with ganciclovir berejection were not fulfilled. In four of the eight biopsy specimens, parenchymal small foci of inflammatory cells were also cause of clinical CMV disease. Two patients (patients 2 and 5) who had a pure HHV-6 recorded. Six patients received high doses of steroids as antirejection treatment (with OKT3 or antithymocyte globulin in four infection 9 months and 3 years, respectively, after transplanta- tion, without CMV infection or rejection, had significant graft sporadic reports concerning liver transplant recipients have dysfunction (figure 2). HHV-6 antigens were also detected in been published [16, 18, 19, 23] . It has also been shown that the grafts. The graft histology demonstrated a mild to moderate, reactivations or reinfections in immunosuppressed individuals, nonspecific portal inflammatory infiltration with lymphocytic such as with other viruses of the herpesvirus family (e.g., predominance. In addition, inflammatory foci with lympho-CMV), are quite common [24] . Even in normal children, the cytes and neutrophils were seen in the parenchyma. Increases frequency of HHV-6 reactivations was reported to be as high in serum values of ALT, ALP, g-GT, and bilirubin lasted a as 16% over a period of 1 -2 years in a prospective study [25] . couple of months, but the values stabilized thereafter (figure Among our 121 adult liver transplant recipients, eight cases 2). The level of HHV-6 antibodies increased slowly up to titers of serologically diagnosed HHV-6 infection were recorded, and of 640 -1,280 and remained high for several months. These only two cases were pure HHV-6 infection not associated with patients were not treated with ganciclovir, but one of them rejections or CMV infection reactivations. However, our study received aciclovir for a few days, without any response in terms was retrospective, and the material represents only those cases of liver function.
diagnosed because of the evidence of graft dysfunction or cliniAll patients who had an episode of HHV-6 infection are cal symptoms. The number of diagnosed reactivations would alive, but three patients (patients 3, 5, and 7) had to undergo probably be much higher if the patients were regularly moniretransplantation 7 -36 months after transplantation because of tored for HHV-6 infection. chronic rejection and vanishing bile duct syndrome. Two of Our patients were all adults with reinfection or reactivation the patients have also had episodes of acute rejection and CMV of HHV-6 infection and rather mild clinical signs or symptoms. infection. One patient (patient 5) had pure HHV-6 infection None of our cases of HHV-6 infection was considered to be without CMV infection or acute rejection. This patient had hepatitis at histology, as described previously in a case report persistently high HHV-6 titers, and antigen was detected in of a primary infection [18] . Other investigators have reported several liver biopsy specimens and in the explanted graft at that the presence of HHV-6 DNA can be detected by PCR in retransplantation 30 months later.
the blood of liver transplant recipients without any significant clinical symptoms at a frequency of 28% [23] . In general, it Discussion is possible that if the patient already has a diagnosed rejection and/or CMV infection explaining clinical symptoms such as HHV-6 infection has been reported to occur in a small number of kidney transplant recipients [12 -16] , and only a few fever or graft dysfunction, additional tests to detect HHV-6-/ 9c48$$mr49 02-11-98 09:46:29 cida UC: CID infection reactivations are not usually considered. On the other HHV-6 seropositive, PCR techniques to demonstrate viral DNA do not necessarily prove that there is an active infection hand, in those cases of unexplained graft dysfunction, we should be more active in obtaining specimens to diagnose a (reactivation), but demonstration of mRNA by PCR would be very helpful in determining the exact timing of infection and possible HHV-6-infection reactivation.
As both HHV-6-specific early antigens and variant B antiinvestigating the association between HHV-6 and allograft rejection. gens were demonstrated in the graft, it seemed that all the diagnosed HHV-6 infections in our liver transplant recipients An association between CMV and HHV-6 infections has been noted in kidney transplant recipients [15, 16] . Among our were actually caused by the variant B virus. The variant B virus is more prevalent than the variant A and possibly associliver transplant recipients who developed HHV-6 infection, CMV antigenemia was closely associated with diagnosis of ated with a different disease [24] . The HHV-6 subgroup B is responsible for most of the cases of primary infections docu-HHV-6 infection in five cases, and in four of those cases CMV was also found in the graft. Probably both of these herpesvimented in early childhood and etiologically associated with exanthema subitum [26] .
ruses, which are close relatives and have genomic homologues, can also reactivate in similar situations, e.g., with increased According to our results, HHV-6 infection can be detected in the liver graft. In kidney allografts, HHV-6-specific antigens immunosuppression during rejection episodes. Among our patients, the combination of rejection and CMV and HHV-6 inhave been found in infiltrating cells and in the epithelial cells of the distal tubuli [14, 15] . We could not find HHV-6 antigens fection was recorded in five cases. Whether both herpesviruses triggered acute rejection or were activated due to rejection or in the parenchymal structures of the liver, and the virus-positive cells were graft-infiltrating leukocytes, mainly lymphocytes.
immunosuppression remains unproven, as does whether CMV and HHV-6 somehow activate mutually, which was suggested Although infected parenchymal cells were not detected, liver dysfunction was associated with the serodiagnosis and the presin a previous study of renal transplantation [16] . Those patients with pure HHV-6 infection also had lymphoence of HHV-6 in the graft and was probably due to infection of the graft itself. To determine whether the virus was of donor cytic infiltration of the graft, which was demonstrated in biopsy histology. Various degrees of lymphocytosis have been deor recipient origin, isolation of the strains and further gene sequence analysis would be needed.
scribed to be associated with other viral infections as well, especially those with CMV and hepatitis C virus [32] . This For decades, the viruses of the herpesvirus family, especially CMV, have been suggested to be associated with rejection or type of nonspecific lymphocytic infiltration, which does not fulfill the criteria of rejection, may be due just to the immunoreeven to trigger it. We and other investigators have recorded an association between chronic liver allograft rejection and sponse against the virus but can make the differential diagnosis difficult in borderline cases of acute rejection. One of our papersistent CMV infection [27, 28] . Whether HHV-6, as a close relative of CMV, may trigger the rejection cascade is not yet tients was treated for rejection due to graft dysfunction, although the biopsy histology was inconclusive. Furthermore, in proven. In the publications concerning renal transplantation, an association between HHV-6 and allograft rejection has been two patients with HHV-6 and CMV infections, acute rejection was suspected only from biopsy histologic findings, and antirerecorded [14, 15] . Acute rejections were significantly more frequent in recipients with HHV-6 infections [14] , and in bijection therapy was administered with a good response. We do not know yet whether HHV-6 (or CMV) -associated opsy specimens obtained during allograft rejection, HHV-6 antigen was common [15] .
inflammation or other histopathologic changes may be falsely interpreted as borderline or mild rejection, in spite of using the The involvement of the viral infection in rejection is possible because immunologic virus-host interactions have also been criteria of the International Working Party [22] , if the patient does not develop a clear picture of hepatitis. documented, and HHV-6 infection has been shown to induce the release of IFN-a and inflammatory cytokines, such as TNFIn summary, HHV-6 may be reactivated and cause clinical problems, at least graft dysfunction after liver transplantation. a and IL-1b [29, 30] . In our study, HHV-6 infection was in most cases detected in association with acute rejection and was HHV-6 antigens are detectable in the liver allograft during the infection episode. HHV-6 reactivations are often associated detected in all three cases involving retransplantation due to chronic rejection.
with rejections and CMV infection. HHV-6 antigen positivity is associated with lymphocyte infiltration of the graft, and the For five of our liver transplant recipients, antirejection treatment preceded the HHV-6 diagnosis. However, we do not know HHV-6-infected cells are located within the cellular infiltrate of the portal areas. whether the infection had already started before rejection, was concomitant with rejection, or occurred after rejection because of increased immunosuppression. Determining the exact timing of infection would require frequent monitoring of the virus or
